Myeloablative I-131-Tositumomab with Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Age ≥ 60 Years with B Cell Lymphoma
- Publication date
- 1 June 2014
- Publisher
- American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.